Torrent Historical Balance Sheet

TORNTPHARM

3,031 7.75 0.26%

Trend analysis of Torrent Pharmaceuticals Limited balance sheet accounts such as Total Stockholder Equity of 82.8 B, Property Plant And Equipment Net of 43.2 B, Net Debt of 22.3 B or Retained Earnings of 47.6 B provides information on Torrent Pharmaceuticals' total assets, liabilities, and equity, which is the actual value of Torrent Pharmaceuticals to its prevalent stockholders. By breaking down trends over time using Torrent Pharmaceuticals balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Torrent Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Torrent Pharmaceuticals is a good buy for the upcoming year.

Torrent Pharmaceuticals Inventory

13.26 Billion

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Torrent Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Torrent Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Torrent Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Torrent Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Torrent currently owns. An asset can also be divided into two categories, current and non-current.

Torrent Pharmaceuticals Balance Sheet Chart

As of now, Torrent Pharmaceuticals' Property Plant And Equipment Net is increasing as compared to previous years. The Torrent Pharmaceuticals' current Retained Earnings is estimated to increase to about 47.6 B, while Short and Long Term Debt Total is projected to decrease to under 27.1 B.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Net Debt Current Deferred Revenue

Add Fundamental

Total Assets

Total assets refers to the total amount of Torrent Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Torrent Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Torrent Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Torrent Pharmaceuticals Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Most accounts from Torrent Pharmaceuticals' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Torrent Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Torrent Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	53.7B	40.2B	46.3B	27.1B
Total Assets	150.1B	150.6B	173.2B	181.9B

Short Long Term Debt Total Total Assets

Torrent Pharmaceuticals balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Accounts Payable	Short Term Investments	Intangible Assets	Current Deferred Revenue	Short Term Debt
Total Assets		0.82	0.63	0.99	0.97	0.99	0.8	0.86	0.42	0.99	0.39	0.36	0.77	0.48	0.81	0.85	0.31	0.26	0.87	0.82	0.81	0.77	0.19	0.97	-0.04	0.86
Short Long Term Debt Total	0.82		0.63	0.83	0.67	0.78	0.99	0.49	0.05	0.84	0.16	0.32	0.77	0.09	0.97	0.85	0.39	-0.18	0.97	0.8	0.42	0.77	0.23	0.88	-0.05	0.9
Other Current Liab	0.63	0.63		0.62	0.57	0.64	0.59	0.42	0.29	0.6	0.34	0.41	0.59	0.28	0.66	0.72	0.46	0.14	0.7	0.72	0.27	0.74	0.17	0.56	-0.16	0.54
Total Current Liabilities	0.99	0.83	0.62		0.95	0.98	0.8	0.85	0.48	0.99	0.34	0.34	0.77	0.48	0.81	0.84	0.29	0.28	0.87	0.81	0.81	0.77	0.13	0.97	-0.11	0.87
Total Stockholder Equity	0.97	0.67	0.57	0.95		0.97	0.65	0.95	0.48	0.95	0.4	0.29	0.7	0.58	0.65	0.82	0.24	0.39	0.75	0.77	0.88	0.68	0.11	0.9	-0.01	0.79
Property Plant And Equipment Net	0.99	0.78	0.64	0.98	0.97		0.75	0.89	0.47	0.98	0.31	0.29	0.75	0.49	0.76	0.87	0.33	0.27	0.84	0.8	0.8	0.74	0.09	0.94	-0.1	0.85
Net Debt	0.8	0.99	0.59	0.8	0.65	0.75		0.45	-0.04	0.82	0.17	0.3	0.73	0.05	0.97	0.81	0.4	-0.24	0.94	0.76	0.38	0.72	0.28	0.87	-0.02	0.87
Retained Earnings	0.86	0.49	0.42	0.85	0.95	0.89	0.45		0.59	0.86	0.31	0.15	0.6	0.66	0.45	0.69	0.07	0.57	0.59	0.62	0.92	0.52	-0.08	0.8	-0.03	0.71
Cash	0.42	0.05	0.29	0.48	0.48	0.47	-0.04	0.59		0.38	0.07	0.17	0.35	0.58	0.04	0.25	-0.15	0.72	0.19	0.3	0.65	0.38	-0.35	0.3	-0.25	0.24
Non Current Assets Total	0.99	0.84	0.6	0.99	0.95	0.98	0.82	0.86	0.38		0.31	0.26	0.73	0.47	0.81	0.84	0.27	0.24	0.87	0.77	0.79	0.72	0.12	0.99	-0.07	0.9
Non Currrent Assets Other	0.39	0.16	0.34	0.34	0.4	0.31	0.17	0.31	0.07	0.31		0.76	0.23	0.36	0.31	0.17	0.21	0.28	0.27	0.43	0.42	0.44	0.78	0.3	0.12	0.04
Cash And Short Term Investments	0.36	0.32	0.41	0.34	0.29	0.29	0.3	0.15	0.17	0.26	0.76		0.4	0.09	0.48	0.31	0.27	-0.01	0.45	0.63	0.27	0.66	0.81	0.25	0.27	0.08
Net Receivables	0.77	0.77	0.59	0.77	0.7	0.75	0.73	0.6	0.35	0.73	0.23	0.4		0.19	0.8	0.87	0.38	0.06	0.87	0.91	0.55	0.9	0.1	0.71	-0.07	0.72
Common Stock Shares Outstanding	0.48	0.09	0.28	0.48	0.58	0.49	0.05	0.66	0.58	0.47	0.36	0.09	0.19		0.07	0.23	-0.17	0.73	0.18	0.23	0.69	0.24	-0.11	0.42	-0.11	0.3
Non Current Liabilities Total	0.81	0.97	0.66	0.81	0.65	0.76	0.97	0.45	0.04	0.81	0.31	0.48	0.8	0.07		0.82	0.41	-0.19	0.97	0.85	0.4	0.84	0.39	0.84	0.02	0.8
Inventory	0.85	0.85	0.72	0.84	0.82	0.87	0.81	0.69	0.25	0.84	0.17	0.31	0.87	0.23	0.82		0.46	-0.01	0.91	0.92	0.55	0.81	0.09	0.81	0.01	0.86
Other Current Assets	0.31	0.39	0.46	0.29	0.24	0.33	0.4	0.07	-0.15	0.27	0.21	0.27	0.38	-0.17	0.41	0.46		-0.48	0.38	0.42	-0.15	0.41	0.32	0.24	-0.17	0.21
Other Stockholder Equity	0.26	-0.18	0.14	0.28	0.39	0.27	-0.24	0.57	0.72	0.24	0.28	-0.01	0.06	0.73	-0.19	-0.01	-0.48		-0.06	0.03	0.65	0.07	-0.3	0.2	-0.13	0.08
Total Liab	0.87	0.97	0.7	0.87	0.75	0.84	0.94	0.59	0.19	0.87	0.27	0.45	0.87	0.18	0.97	0.91	0.38	-0.06		0.91	0.53	0.88	0.25	0.88	-0.04	0.89
Total Current Assets	0.82	0.8	0.72	0.81	0.77	0.8	0.76	0.62	0.3	0.77	0.43	0.63	0.91	0.23	0.85	0.92	0.42	0.03	0.91		0.58	0.93	0.35	0.74	0.07	0.71
Common Stock	0.81	0.42	0.27	0.81	0.88	0.8	0.38	0.92	0.65	0.79	0.42	0.27	0.55	0.69	0.4	0.55	-0.15	0.65	0.53	0.58		0.52	0.01	0.74	-0.01	0.63
Accounts Payable	0.77	0.77	0.74	0.77	0.68	0.74	0.72	0.52	0.38	0.72	0.44	0.66	0.9	0.24	0.84	0.81	0.41	0.07	0.88	0.93	0.52		0.34	0.69	-0.01	0.63
Short Term Investments	0.19	0.23	0.17	0.13	0.11	0.09	0.28	-0.08	-0.35	0.12	0.78	0.81	0.1	-0.11	0.39	0.09	0.32	-0.3	0.25	0.35	0.01	0.34		0.14	0.39	-0.08
Intangible Assets	0.97	0.88	0.56	0.97	0.9	0.94	0.87	0.8	0.3	0.99	0.3	0.25	0.71	0.42	0.84	0.81	0.24	0.2	0.88	0.74	0.74	0.69	0.14		-0.05	0.92
Current Deferred Revenue	-0.04	-0.05	-0.16	-0.11	-0.01	-0.1	-0.02	-0.03	-0.25	-0.07	0.12	0.27	-0.07	-0.11	0.02	0.01	-0.17	-0.13	-0.04	0.07	-0.01	-0.01	0.39	-0.05		-0.15
Short Term Debt	0.86	0.9	0.54	0.87	0.79	0.85	0.87	0.71	0.24	0.9	0.04	0.08	0.72	0.3	0.8	0.86	0.21	0.08	0.89	0.71	0.63	0.63	-0.08	0.92	-0.15

Click cells to compare fundamentals

Torrent Pharmaceuticals Account Relationship Matchups

Torrent Pharmaceuticals balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	140.7B	131.0B	150.1B	150.6B	173.2B	181.9B
Short Long Term Debt Total	48.7B	40.7B	53.7B	40.2B	46.3B	27.1B
Other Current Liab	8.0B	7.4B	1.0B	8.1B	9.4B	4.9B
Total Current Liabilities	48.9B	44.2B	54.5B	54.3B	62.4B	65.5B
Total Stockholder Equity	58.4B	59.5B	62.0B	68.6B	78.8B	82.8B
Property Plant And Equipment Net	36.3B	32.5B	34.6B	35.8B	41.1B	43.2B
Net Debt	43.0B	36.7B	48.6B	31.9B	36.6B	22.3B
Retained Earnings	28.1B	29.2B	33.0B	39.4B	45.3B	47.6B
Cash	5.7B	4.0B	5.1B	8.4B	9.6B	10.1B
Non Current Assets Total	85.5B	79.3B	97.0B	94.5B	108.7B	114.1B
Non Currrent Assets Other	1.1B	3.2B	2.0B	9.0B	10.4B	10.9B
Cash And Short Term Investments	7.4B	5.8B	8.4B	10.0B	11.5B	8.0B
Net Receivables	18.9B	19.2B	19.5B	18.4B	21.2B	12.3B
Liabilities And Stockholders Equity	140.7B	131.0B	150.1B	150.6B	173.2B	181.9B
Non Current Liabilities Total	33.5B	27.3B	33.7B	27.8B	32.0B	20.6B
Inventory	26.8B	24.6B	22.3B	22.8B	26.2B	13.3B
Other Current Assets	21.0B	21.2B	3.0B	4.8B	5.6B	8.4B
Total Liab	82.4B	71.5B	88.1B	82.0B	94.4B	50.0B
Total Current Assets	55.2B	51.6B	53.1B	56.1B	64.5B	35.6B
Accumulated Other Comprehensive Income	29.4B	29.5B	27.3B	27.4B	31.6B	33.1B
Accounts Payable	20.7B	16.7B	16.8B	20.9B	24.0B	15.0B
Short Term Investments	1.7B	1.8B	3.3B	1.7B	1.9B	3.6B
Intangible Assets	39.8B	35.5B	50.9B	45.8B	52.7B	55.3B
Current Deferred Revenue	7.9B	7.3B	8.5B	45M	40.5M	38.5M
Short Term Debt	19.7B	19.5B	28.2B	23.5B	27.1B	15.5B
Other Liab	3.2B	4.3B	3.8B	5.7B	6.6B	4.2B
Net Tangible Assets	(3.6B)	1.1B	15.1B	21.5B	19.3B	20.3B
Other Assets	6.9B	5.3B	6.8B	5.4B	6.3B	3.9B
Long Term Debt	29.4B	21.2B	25.0B	16.0B	18.4B	27.5B
Short Long Term Debt	7.0B	19.0B	28.0B	23.3B	26.8B	16.9B
Property Plant Equipment	35.3B	36.3B	32.5B	34.6B	39.8B	30.0B
Good Will	3.4B	2.6B	3.4B	3.4B	3.9B	3.0B
Long Term Debt Total	33.0B	29.6B	21.6B	25.5B	29.3B	31.8B
Non Current Liabilities Other	50M	40M	20M	10M	11.5M	10.9M
Cash And Equivalents	2.6B	149.3M	228.1M	379.8M	341.8M	324.7M
Net Invested Capital	65.4B	99.7B	115.0B	107.9B	97.1B	81.4B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Other Information on Investing in Torrent Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Torrent Historical Balance Sheet

Torrent Pharmaceuticals Inventory

13.26 Billion

About Torrent Balance Sheet Analysis

Torrent Pharmaceuticals Balance Sheet Chart

Total Assets

Total Current Liabilities

Net Debt

Current Deferred Revenue

Torrent Pharmaceuticals balance sheet Correlations

Torrent Pharmaceuticals Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Torrent Pharmaceuticals balance sheet Accounts

Also Currently Popular

Other Information on Investing in Torrent Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Non Current Assets Total	+ 0.99	Total Current Liabilities
Intangible Assets	+ 0.99	Non Current Assets Total

Other Stockholder Equity	- 0.48	Other Current Assets
Short Term Investments	- 0.35	Cash
Short Term Investments	- 0.3	Other Stockholder Equity
Current Deferred Revenue	- 0.25	Cash
Other Stockholder Equity	- 0.24	Net Debt
Other Stockholder Equity	- 0.19	Non Current Liabilities Total